MetLife Investment Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,701
| Closed | -$781K | – | 2951 |
|
|
2024
Q1 | $781K | Buy |
19,701
+2,883
| +17% | +$114K | 0.01% | 1438 |
|
|
2023
Q4 | $321K | Hold |
16,818
| – | – | ﹤0.01% | 1953 |
|
|
2023
Q3 | $193K | Hold |
16,818
| – | – | ﹤0.01% | 2234 |
|
|
2023
Q2 | $173K | Buy |
16,818
+4,790
| +40% | +$49.2K | ﹤0.01% | 2370 |
|
|
2023
Q1 | $92.9K | Hold |
12,028
| – | – | ﹤0.01% | 2582 |
|
|
2022
Q4 | $88.4K | Buy |
+12,028
| New | +$88.4K | ﹤0.01% | 2637 |
|